KCAS Bio Strengthens Board of Directors with Appointment of Paul Kirchgraber and Kurt Doyle

Contributed by: Business Wire

Tags

Health
General Health
Clinical Trials
Research
Science
Pharmaceutical
Biotechnology
Vitruvian Partners, Paul Kirchgraber, Kurt Doyle

More Like This

The KCAS Bio – Lyon, France Site Renews Its GLP Compliance Statement, Strengthening Its Support for IND-Enabling Studies Through Bioanalysis and Biomarkers

GlobeNewswire associated0

4BIO Capital Strengthens Advisory Board and Investment Team

PK MED Strengthens Its Strategic and Scientific Governance to Support the Development of Its Therapeutic Micro-implants

Business Wire logo

Kaitie Kramer Joins Parse Biosciences as Vice President of Marketing

Biosynth Names Matt Gunnison as CEO, Kieran Murphy Appointed as Chairman

Peter Carbone, KBI Biopharma Chief Quality Officer (Photo: Business Wire)

KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer

PR Newswire associated0

Bio X Cell Announces Board of Director Appointments

Business Wire logo

Clinilabs Announces Medical Leadership Appointments